BPP, a dual functional inhibitor, targets MLL-rearranged acute myeloid leukemia: Unraveling mechanisms and expanding therapeutic horizons

被引：0
|
作者：
Chen, Tai-Lin
Su, Tsann-Long
Lee, Te-Chang
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3330
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3330
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Chromatin modifications as therapeutic targets in MLL-rearranged leukemia
    Deshpande, Aniruddha J.
    Bradner, James
    Armstrong, Scott A.
    TRENDS IN IMMUNOLOGY, 2012, 33 (11) : 563 - 570
  • [2] The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia
    B V Balgobind
    C M Zwaan
    R Pieters
    M M Van den Heuvel-Eibrink
    Leukemia, 2011, 25 : 1239 - 1248
  • [3] The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia
    Balgobind, B. V.
    Zwaan, C. M.
    Pieters, R.
    Van den Heuvel-Eibrink, M. M.
    LEUKEMIA, 2011, 25 (08) : 1239 - 1248
  • [4] Prognosis of Children with MLL-rearranged Acute Myeloid Leukemia
    Yamamori, Ayako
    Maemura, Ryo
    Wakamatsu, Manabu
    Sakaguchi, Hirotoshi
    Yoshida, Nao
    Kato, Koji
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S72 - S72
  • [5] The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
    Wu, Wenqi
    Jiang, Yanan
    Xing, Donghui
    Zhai, Yixin
    Sun, Huimeng
    He, Xiang
    Luo, Kaiping
    Xu, Pengpeng
    Pan, Feng
    Dong, Guolei
    Ren, Guibing
    Zhao, Zhigang
    CELL DEATH DISCOVERY, 2024, 10 (01)
  • [6] BET INHIBITOR AS A NOVEL THERAPEUTIC APPROACH FOR THE TREATMENT OF MLL-REARRANGED INFANT ACUTE LEUKEMIA
    Bardini, M.
    Trentin, L.
    Rizzo, F.
    Vieri, M.
    Savino, A. M.
    Castro, P. Garrido
    Fazio, G.
    Van Roon, E.
    Smithers, N.
    Prinjha, R.
    Stam, R.
    Pieters, R.
    te Kronnie, G.
    Basso, G.
    Biondi, A.
    Cazzaniga, G.
    HAEMATOLOGICA, 2016, 101 : 323 - 323
  • [7] REQUIREMENT FOR CDK6 IN MLL-REARRANGED ACUTE MYELOID LEUKEMIA
    Placke, T.
    Faber, K.
    Nonami, A.
    Putwain, S.
    Salih, H.
    Heidel, F.
    Kraemer, A.
    Root, D.
    Barbie, D.
    Armstrong, S.
    Hahn, W.
    Huntly, B.
    Sykes, S.
    Milsom, M.
    Scholl, C.
    Froehling, S.
    HAEMATOLOGICA, 2014, 99 : 513 - 513
  • [8] Requirement for CDK6 in MLL-rearranged acute myeloid leukemia
    Placke, Theresa
    Faber, Katrin
    Nonami, Atsushi
    Putwain, Sarah L.
    Salih, Helmut R.
    Heidel, Florian H.
    Kraemer, Alwin
    Root, David E.
    Barbie, David A.
    Krivtsov, Andrei V.
    Armstrong, Scott A.
    Hahn, William C.
    Huntly, Brian J.
    Sykes, Stephen M.
    Milsom, Michael D.
    Scholl, Claudia
    Froehling, Stefan
    BLOOD, 2014, 124 (01) : 13 - 23
  • [9] The inhibitory effect of a novel DOT1L inhibitor in MLL-rearranged acute myeloid leukemia
    Liu, Wei
    Liu, Wei
    Deng, Lisheng
    Song, Yongcheng
    Redell, Michele
    Redell, Michele
    CANCER RESEARCH, 2013, 73
  • [10] TGIF1 is a negative regulator of MLL-rearranged acute myeloid leukemia
    Willer, A.
    Jakobsen, J. S.
    Ohlsson, E.
    Rapin, N.
    Waage, J.
    Billing, M.
    Bullinger, L.
    Karlsson, S.
    Porse, B. T.
    LEUKEMIA, 2015, 29 (05) : 1018 - 1031
12345